Pharmacokinetic Profiles of LY03003 and Neupro

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Phase 1, single center study to assess pharmacokinetic profiles of rotigotine after single dose of LY03003 and daily patch application of Neupro in Healthy Volunteers

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - LY03003

LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)

Drug - Neupro 4Mg/24Hr Transdermal Patch

neupro patch

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers